Axepta
Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant, which makes it an option for those who cannot tolerate stimulant medicines.
- Categories
- Mental Health · ADHD & Focus
- Active ingredient
- Atomoxetine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10mg · 18mg · 25mg · 40mg
Prescription and consultation requirements for Axepta vary by destination and are determined by the fulfilment partner.
Axepta details
- Alternative names
- atomoxetine
- Therapeutic class
- Selective Norepinephrine Reuptake Inhibitor (SNRI)
- Pharmacological class
- Non-Stimulant ADHD Agent
- Known off-label uses
- narcolepsy
- Contraindications
- narrow-angle glaucoma; pheochromocytoma; MAO inhibitor therapy
- Minor side effects
- nausea; decreased appetite; somnolence
- Moderate side effects
- dry mouth; erectile dysfunction; insomnia
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Torrent Pharmaceuticals Ltd
- Onset Time
- 2–4 weeks
- Duration
- 12–24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- MAO Inhibitors; Fluoxetine; Paroxetine
- Age restrictions
- Approved for children over six years, adolescents, and adults.
- Pregnancy and breastfeeding
- Pregnancy: Use if clinically needed. Breastfeeding: Consult a doctor.
Serious side effects
suicidal ideation, requires immediate medical attention; severe hepatotoxicity, requires immediate medical attention
Patient summary
Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant, which makes it an option for those who cannot tolerate stimulant medicines.
Mechanism of action
Selectively inhibits the presynaptic norepinephrine transporter, elevating extracellular transmitter levels in the prefrontal cortex.